BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

Kadimastem, Merck KGaA deal

Merck's Merck Serono S.A. division signed a memorandum of understanding to extend an April 2012 deal to use the Israeli company's drug-screening technology to...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >